Stocktoria
Progyny, Inc. PGNY
Nasdaq · XNAS · stock · Services-Misc Health & Allied Services, NEC · website · IPO 2019-10-25
Progyny, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.2B | $1.1B | $786.9M | $500.6M |
| Gross profit | $304.5M | $253.4M | $238.8M | $167.3M | $112.1M |
| R&D expense | $9.5M | — | — | — | — |
| Operating income | $85.3M | $67.5M | $62.2M | $23.3M | $32.3M |
| Income tax | $36.9M | $28.9M | $8.7M | -$5.9M | -$33.3M |
| Net income | $58.5M | $54.3M | $62.0M | $30.4M | $65.8M |
| EPS (diluted) | $0.65 | $0.57 | $0.62 | $0.30 | $0.66 |
| Operating cash flow | $210.2M | $179.1M | $188.8M | $80.4M | $26.0M |
| Free cash flow | $191.8M | $173.7M | $185.2M | $77.2M | $23.9M |
| Cash & equivalents | $112.2M | $162.3M | $97.3M | $120.1M | $91.4M |
| Total assets | $742.4M | $607.1M | $756.6M | $543.0M | $358.1M |
| Total liabilities | $226.4M | $185.0M | $203.2M | $166.0M | $106.2M |
| Shareholders' equity | $516.0M | $422.1M | $553.4M | $377.0M | $251.8M |
Source: SEC EDGAR filings · CIK 0001551306 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.